XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Stockholders’ Deficit (Tables)

6 Months Ended

Jun. 30, 2024

Stockholders’ Deficit [Abstract]

Schedule of Compensation Expense Related Restricted Stock Awards

The table below summarizes the compensation expense related to the Company’s restricted stock awards for the six months ended June 30:

		2024				2023
Directors
February 23, 2023: 168,419 share grant of common stock		$	70,000			$	-
Consultants
October 20, 2021: 17,274 share grant for common stock			-				146,000
October 22, 2021: 8,637 share grant for common stock			-				62,000
October 26, 2021: 17,274 share grant for common stock			-				122,000
Employees
June 19, 2023; 675,058 share grant of common stock			278,000				38,000
April 4, 2022: 166,667 share grant for common stock			-				395,000
Stock-based compensation expense reversal for April 4, 2022 grant			-				(1,910,000	)
Other
Officer contributed capital			-				126,000
		$	348,000			$	(1,021,000	)

Schedule of Warrants Transactions

Transactions involving warrants are as follows for the six months ended June 30, 2024:

		Number of Shares				Weighted Average Strike Price/Share				Weighted Average Remaining Contractual Term (Years)				Weighted Average Grant Date Fair Value				Weighted Average Intrinsic Value
Outstanding – December 31, 2023			1,844,781			$	9.84				1.39			$	5.81			$	1.19
Granted			-				-				-				-				-
Exercised			165,622				0.006				0.75				9.06				1.48
Expired			1,652,851				10.98				-				7.55				-
Outstanding – June 30, 2024			26,308				0.006				0.50				0.14				1.18
Vested and exercisable – June 30, 2024			26,308				0.006				0.50				0.14				1.18
Unvested and non-exercisable – June 30, 2024			-			$	-				-			$	-			$	-

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration